Biotech Values

[corpstrat]

<<DNA is Roche and Roche is DNA>>

Not in terms of management of R&D they're not. Couldn't be more different. Which is presumably why such a high proportion of Roche's pharma revenues is earned from DNA drugs. The acquisition will prove value destructive imo. And from a societal point of view will divert a lot of cash that payors shell out for high-priced biologics into less productive channels than currently is the case.